Crawford Russell M, Treharne Kate J, Arnaud-Dabernat Sandrine, Daniel Jean-Yves, Foretz Marc, Viollet Benoit, Mehta Anil
Department of Maternal and Child Health Sciences, University of Dundee, Dundee DD1 9SY, United Kingdom.
Mol Cell Biol. 2006 Aug;26(15):5921-31. doi: 10.1128/MCB.00315-06.
Nucleoside diphosphate kinase (NDPK) (nm23/awd) belongs to a multifunctional family of highly conserved proteins (approximately 16 to 20 kDa) including two well-characterized isoforms (NDPK-A and -B). NDPK catalyzes the conversion of nucleoside diphosphates to nucleoside triphosphates, regulates a diverse array of cellular events, and can act as a protein histidine kinase. AMP-activated protein kinase (AMPK) is a heterotrimeric protein complex that responds to the cellular energy status by switching off ATP-consuming pathways and switching on ATP-generating pathways when ATP is limiting. AMPK was first discovered as an activity that inhibited preparations of acetyl coenzyme A carboxylase 1 (ACC1), a regulator of cellular fatty acid synthesis. We recently reported that NDPK-A (but not NDPK-B) selectively regulates the alpha1 isoform of AMPK independently of the AMP concentration such that the manipulation of NDPK-A nucleotide trans-phosphorylation activity to generate ATP enhanced the activity of AMPK. This regulation occurred irrespective of the surrounding ATP concentration, suggesting that "substrate channeling" was occurring with the shielding of NDPK-generated ATP from the surrounding medium. We speculated that AMPK alpha1 phosphorylated NDPK-A during their interaction, and here, we identify two residues on NDPK-A targeted by AMPK alpha1 in vivo. We find that NDPK-A S122 and S144 are phosphorylated by AMPK alpha1 and that the phosphorylation status of S122, but not S144, determines whether substrate channeling can occur. We report the cellular effects of the S122 mutation on ACC1 phosphorylation and demonstrate that the presence of E124 (absent in NDPK-B) is necessary and sufficient to permit both AMPK alpha1 binding and substrate channeling.
核苷二磷酸激酶(NDPK)(nm23/awd)属于一个高度保守的多功能蛋白家族(约16至20 kDa),包括两种特征明确的同工型(NDPK-A和-B)。NDPK催化核苷二磷酸转化为核苷三磷酸,调节多种细胞事件,并可作为蛋白组氨酸激酶。AMP活化蛋白激酶(AMPK)是一种异源三聚体蛋白复合物,当ATP受限时,它通过关闭ATP消耗途径和开启ATP生成途径来响应细胞能量状态。AMPK最初是作为一种抑制乙酰辅酶A羧化酶1(ACC1)制剂的活性被发现的,ACC1是细胞脂肪酸合成的调节剂。我们最近报道,NDPK-A(而非NDPK-B)独立于AMP浓度选择性调节AMPK的α1同工型,因此操纵NDPK-A核苷酸转磷酸化活性以生成ATP可增强AMPK的活性。这种调节与周围ATP浓度无关,表明发生了“底物通道化”,即NDPK生成的ATP被与周围介质隔离。我们推测AMPKα1在与NDPK-A相互作用期间使其磷酸化,在此,我们鉴定出体内AMPKα1靶向的NDPK-A上的两个残基。我们发现NDPK-A的S122和S144被AMPKα1磷酸化,并且S122而非S144的磷酸化状态决定了是否能发生底物通道化。我们报道了S122突变对ACC1磷酸化的细胞效应,并证明E124(NDPK-B中不存在)的存在对于允许AMPKα1结合和底物通道化是必要且充分的。